Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating three topical regimens for acne vulgaris: clindamycin-retinoid, clindamycin-retinoid-dexamethasone, and 10% SM-hUCMSC secr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 10% SM-hUCMSC secretome gel
  • Clindamycin-Retinoid
  • Clindamycin-Retinoid-Dexamethasone

Snippet

Sponsor: Yohanes Firmansyah, dr, MH, MM | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING